TI
Talat Imran
Chief Executive Officer

Talat Imran insider trades: Rani Therapeutics Holdings (RANI) stock buys and sales

Chief Executive Officer, Rani Therapeutics Holdings Last trade Jul 17, 2026 16 Form 4 filings
$0
Sold, last 12 months
0 sales
$25K
Bought, last 12 months
1 buy
7
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Talat reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 17, 2026RANI↑ Buy$25K
Dec 27, 2024RANI↓ Sell$11K
Dec 9, 2024RANI↑ Buy$20K
Dec 6, 2023RANI↑ Buy$23K
Dec 4, 2023RANI↑ Buy$13K
Nov 29, 2023RANI↑ Buy$41K
Nov 7, 2023RANI↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RANI insiders

Open-market trades in the last 12 months

About Talat Imran's insider trades

Talat Imran is Chief Executive Officer at Rani Therapeutics Holdings (RANI). Since Nov 7, 2023, Talat has reported 6 open-market purchases worth $132K and 1 sale worth $11K on SEC Form 4. In the last 12 months: 1 buy ($25K).

Their filings also include grants and awards (6 filings), shares withheld for taxes (3 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RANI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.